Can Cosentyx Be Taken with Immunosuppressants?
No, Cosentyx (secukinumab) should not be used with systemic immunosuppressants like azathioprine or cyclosporine. The prescribing information warns against concurrent use due to increased infection risk from combined immune suppression.[1]
Why the Combination Raises Concerns
Cosentyx, an IL-17A inhibitor for psoriasis, psoriatic arthritis, and ankylosing spondylitis, weakens immune responses. Adding other immunosuppressants amplifies this, heightening chances of serious infections like tuberculosis reactivation or opportunistic pathogens. Live vaccines are also avoided during treatment.[1]
What Happens If Combined Anyway?
Physicians may monitor closely in rare cases, but official guidance prohibits it. Post-marketing data shows elevated infection rates with biologics like Cosentyx alongside steroids or methotrexate, though methotrexate is sometimes allowed at low doses with caution.[1][2]
Common Immunosuppressants to Avoid
- Azathioprine
- Cyclosporine
- Methotrexate (high doses; low doses sometimes co-used)
- Corticosteroids (systemic high doses)
TNF inhibitors like Humira overlap in risk and are not combined with Cosentyx.[1]
Safer Alternatives for Combination Therapy
For patients needing multiple agents:
- Low-dose methotrexate with Cosentyx is studied and tolerated in some trials for psoriatic arthritis.
- Switch to non-biologic options like apremilast (Otezla), which has fewer interactions.
- Tofacitinib (Xeljanz) or other JAK inhibitors may pair differently but require similar infection vigilance.[2][3]
What Patients Report and Doctor Advice
Forum discussions and patient reviews note fatigue and infections when mixing biologics informally, prompting FDA black-box warnings on infections for IL-17 drugs. Always consult a rheumatologist; drug interaction checkers like Drugs.com flag major risks.[2]
[1]: Cosentyx Prescribing Information (Novartis)
[2]: Drugs.com - Cosentyx Interactions
[3]: FDA Label for Secukinumab